S Ozsoylu. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Bone Marrow/pathologyBreast Neoplasms/pathologyBreast Neoplasms/therapyCombined Modality TherapyFemaleHumansLeukemia, Myeloid/pathologyLeukemia, Myeloid/therapyMethylprednisolone/administration & dosageSkin Neoplasms/pathologySkin Neoplasms/therapyTreatment OutcomeUnnecessary Procedures
Substances: See more » Methylprednisolone
Year: 2001 PMID: 11408719 DOI: 10.1159/000046549
Source DB: PubMed Journal: Acta Haematol ISSN: 0001-5792 Impact factor: 2.195